Association analysis of the adenosine A1 receptor gene polymorphisms in patients with methamphetamine dependence/psychosis

Current Neuropharmacology

Volumn 9, Issue 1, 2011, Pages 137-142

  Kobayashi, Hideaki ^a,k   Ujike, Hiroshi ^b,j   Iwata, Nakao ^c,j   Inada, Toshiya ^d,j   Yamada, Mitsuhiko ^e,j   Sekine, Yoshimoto ^f,j   Uchimura, Naohisa ^g,j   Iyo, Masaomi ^f,j   Ozaki, Norio ^h,j   Itokawa, Masanari ⁱ   Sora, Ichiro ^a,j  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SEIWA HOSPITAL   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f CHIBA UNIVERSITY   (Japan)

^g KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^j Japanese Genetics Initiative for Drug Abuse ^*  (Japan)

^k NIHON UNIVERSITY   (Japan)

more..

Author keywords

Abuse; Dopamine; Human; Japanese; MAP; Single nucleotide polymorphism; SNP; Variation

Indexed keywords

ADENOSINE A1 RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DEPENDENCE; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; JAPANESE; MALE; METHAMPHETAMINE DEPENDENCE; NUCLEOTIDE SEQUENCE; PSYCHOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79953047292     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015911795016958     Document Type: Article

References (23)

1. Matsumoto, T.; Kamijo, A.; Miyakawa, T.; Endo, K.; Yabana, T.; Kishimoto, H.; Okudaira, K.; Iseki, E.; Sakai, T.; Kosaka, K. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction, 2002, 97(7), 809-817.
2. Volkow, N.D.; Chang, L.; Wang, G.J.; Fowler, J.S.; Leonido-Yee, M.; Franceschi, D.; Sedler, M.J.; Gatley, S.J.; Hitzemann, R.; Ding, Y.S.; Logan, J.; Wong, C.; Miller, E.N. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry, 2001, 158(3), 377-382.
3. Wilson, J.M.; Kalasinsky, K.S.; Levey, A.I.; Bergeron, C.; Reiber, G.; Anthony, R.M.; Schmunk, G.A.; Shannak, K.; Haycock, J.W.; Kish, S.J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med., 1996, 2(6), 699-703.
4. Di Chiara, G.; Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA, 1988, 85(14), 5274-5278.
5. Giros, B.; Jaber, M.; Jones, S.R.; Wightman, R.M.; Caron, M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 1996, 379(6566), 606-612.
6. Ferre, S.; Fredholm, B.B.; Morelli, M.; Popoli, P.; Fuxe, K. Adenosine- dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci., 1997, 20(10), 482-487.
7. Ferre, S.; Fuxe, K.; von Euler, G.; Johansson, B.; Fredholm, B.B. Adenosine-dopamine interactions in the brain. Neuroscience, 1992, 51(3), 501-512.
8. Gines, S.; Hillion, J.; Torvinen, M.; Le Crom, S.; Casado, V.; Canela, E.I.; Rondin, S.; Lew, J.Y.; Watson, S.; Zoli, M.; Agnati, L.F.; Verniera, P.; Lluis, C.; Ferre, S.; Fuxe, K.; Franco, R. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc. Natl. Acad. Sci. USA, 2000, 97(15), 8606-8611.
9. O'Neill, C.; Nolan, B.J.; Macari, A.; O'Boyle, K.M.; O'Connor, J.J. Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors. Eur. J. Neurosci., 2007, 26(12), 3421-3428.
10. Munzar, P.; Justinova, Z.; Kutkat, S.W.; Ferre, S.; Goldberg, S.R. Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology (Berl), 2002, 161(4), 348-355.
11. Justinova, Z.; Ferre, S.; Segal, P.N.; Antoniou, K.; Solinas, M.; Pappas, L.A.; Highkin, J.L.; Hockemeyer, J.; Munzar, P.; Goldberg, S.R. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats. J. Pharmacol. Exp. Ther., 2003, 307(3), 977-986.
12. Delle Donne, K.T.; Sonsalla, P.K. Protection against methamphetamine- induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation. J. Pharmacol. Exp. Ther., 1994, 271(3), 1320-1326.
13. Poleszak, E.; Malec, D. Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats. Pol. J. Pharmacol., 2000, 52(6), 423-429.
14. Turgeon, S.M.; Pollack, A.E.; Schusheim, L.; Fink, J.S. Effects of selective adenosine A1 and A2a agonists on amphetamine-induced locomotion and c-Fos in striatum and nucleus accumbens. Brain Res., 1996, 707(1), 75-80.
15. Poleszak, E.; Malec, D. Effects of adenosine receptor agonists and antagonists in amphetamine-induced conditioned place preference test in rats. Pol. J. Pharmacol., 2003, 55(3), 319-326.
16. Ujike, H.; Harano, M.; Inada, T.; Yamada, M.; Komiyama, T.; Sekine, Y.; Sora, I.; Iyo, M.; Katsu, T.; Nomura, A.; Nakata, K.; Ozaki, N. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics. J, 2003, 3(4), 242-247.
17. Ren, H.; Stiles, G.L. Separate promoters in the human A1 adenosine receptor gene direct the synthesis of distinct messenger RNAs that regulate receptor abundance. Mol. Pharmacol., 1995, 48(6), 975-980.
18. Ujike, H. Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr. Psychiatry Rep., 2002, 4(3), 177-184.
19. Schneider, S.; Roessli, D.; Excoffier, L. Arlequin: a software for population genetics data analysis. Version 2.000. Genetics and Biometry Lab, Department of Anthropology, University of Geneva, 2000.
20. Deckert, J.; Nothen, M.M.; Albus, M.; Franzek, E.; Rietschel, M.; Ren, H.; Stiles, G.L.; Knapp, M.; Weigelt, B.; Maier, W.; Beckmann, H.; Propping, P. Adenosine A1 receptor and bipolaraffective disorder: systematic screening of the gene and association studies. Am. J. Med. Genet., 1998, 81(1), 18-23.
21. Deckert, J.; Nothen, M.M.; Franke, P.; Delmo, C.; Fritze, J.; Knapp, M.; Maier, W.; Beckmann, H.; Propping, P. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol. Psychiatry, 1998, 3(1), 81-85.
22. Alsene, K.; Deckert, J.; Sand, P.; de Wit, H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology, 2003, 28(9), 1694-1702.
23. Hohoff, C.; McDonald, J.M.; Baune, B.T.; Cook, E.H.; Deckert, J.; de Wit, H. Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am. J. Med. Genet. B Neuropsychiatry. Genet., 2005, 139B(1), 42-44.